Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00419302 | To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus. | PHASE2 | COMPLETED | 16 | — | — | Oct 1, 2003 | Apr 1, 2004 | Oct 14, 2009 | 1 | Germany |
| Name | Type | Description |
|---|---|---|
| Technosphere/Insulin | DRUG | - |
Inclusion Criteria: * Clinical diagnosis of type 2 diabetes mellitus. * Current regimen of intensified insulin therapy for at least 6 months. * Body Mass Index less than 35 kg/m2. * HbA1c less than or equal to 9%. * Non-smoker for at least 2 years. * If medications in addition to insulin are taken ...